-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
KVUE Stock Alert: 10 Things to Know as Kenvue Starts Trading
Kenvue (KVUE) stock is set to start trading on Thursday as the company completes its spinoff from Johnson & Johnson (JNJ).
Why Is Altamira Therapeutics (CYTO) Stock Up 45% Today?
Altamira Therapeutics (CYTO) stock is taking off on Thursday despite a lack of news from the RNA-based therapeutics company.
KVUE Stock: Should You Buy Into the Kenvue IPO?
KVUE stock will be a dividend stock with an initial yield of 3.5%, with slow growth and lower margins than JNJ's drug business.
Why Is Akili (AKLI) Stock Up 21% Today?
Akili (AKLI) stock is gaining on Wednesday after the company's video game treatment showed success in reducing ADHD in adults.
Why Is ImmunoGen (IMGN) Stock Up 125% Today?
ImmunoGen (IMGN) stock is rising higher on Wednesday after the company released results from a Phase 3 trial for treating ovarian cancer.
LLY Stock Alert: Eli Lilly Announces Positive Alzheimer’s Drug Data
Eli Lilly (LLY) stock is getting a boost on Wednesday after the company announced results from an Alzheimer's clinical trial.
Why Is Akanda (AKAN) Stock Up 114% Today?
Akanda (AKAN) stock is on the rise Wednesday after the cannabis company released its annual report after saying it would be late.
Why Is Aptorum (APM) Stock Up 166% Today?
Aptorum (APM) stock is climbing higher on Wednesday despite a lack of news from the clinical-stage biopharmaceutical company.
KVUE Stock IPO: When Does Kenvue Go Public? What Is the Kenvue IPO Price Range?
Johnson & Johnson spinoff Kenvue is gearing up to go public on May 4. Here's what investors need to know about KVUE stock and the Kenvue IPO.